Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

CAIV-T vaccine regulatory update

May 21, 2007 7:00 AM UTC

FDA's Vaccines and Related Biological Products Advisory Committee voted in favor of expanding the label of CAIV-T intranasal influenza vaccine to include children 12-59 months of age without history o...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article